|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
FY2011
12 months to Dec 31, 2011
|
|
|---|---|---|---|---|
| Revenues | ||||
| Costs of revenues | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Research and development (net of grants of $5,404, $5,080 and $5,863 for the years ended December 31, 2014, 2013 and 2012, respectively) | ||||
| Selling and marketing | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Financial income, net (see Note 15) | ||||
| Income before taxes on income | ||||
| Net income | ||||
| Basic net income per share | ||||
| Diluted net income per share | ||||
| Weighted average number of Ordinary Shares used in computing basic net income per share | ||||
| Weighted average number of Ordinary Shares used in computing diluted net income per share | ||||
| Unrealized gain (loss) on available-for-sale marketable securities | ||||
| Unrealized gain (loss) on foreign currency cash flow hedges transactions | ||||
| Total comprehensive income | ||||
Loading...
